http://www.amgen.com

Gregory Friberg, MD - Executive Medical Director, Medical Sciences Oncology Early Development
Ada Braun, MD - Executive Medical Director, Global Development
David Reese, MD - VP Medical Sciences
Darrin Beaupre, MD - Medical Director, Medical Sciences

Presentation on:

• Amgen Early Development Pipeline

---

http://www.methylgene.com

Jeffrey Besterman, PhD -Executive Vice President,  Research and Development & Chief Scientific Officer

Presentation on:

• Mocetinostat (MGCD0103)
• MGCD265 - met-kinase inhibitor

---

http://www.antisense.com

Hubert Heinrichs - Chief Medical Officer
Piotr Jachimczak - Senior Scientific Advisor

Presentation on:

• Trabidersen (AP12009)
• AP11014 - TGF-beta 1 expression inhibitor

---

http://www.traconpharma.com

Charles Theuer, MD, PhD - President and CEO

Presentation on:

• TRC093 - recombinant humanized IgG1 MAb
• TRC105 - Human chimeric MAb that bind CD105 

---

http://www.intezyne.com/

1:1 meetings only

---

http://www.ceruleanrx.com/

John Ryan, MD, PhD - Acting Chief Medical Officer
Scott Eliasof, PhD - Vice President of Research

Presentation on:

• CRLX101 - Novel Camptothecin Nanopharmaceutical

---

http://www.abbott.com

Rod Humerickhouse - Global Project Head

Presentation on:

• Abbott Pipeline

---

http://www.acceleronpharma.com/

Matthew Sherman - Chief Medical Officer
John Oram - Program Management
Jonathan Yu - Business and Market Development

Presentation on:

• ACE-041 - Novel angiogenesis inhibitor targeting ALK1

---